Probiotics showed no clear difference in withdrawal due to adverse events compared with placebo (low certainty).
It is very uncertain whether probiotics changes withdrawal due to adverse events compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (very low certainty).
It is very uncertain whether probiotics changes withdrawals due to adverse events compared with magnesium oxide (very low certainty).
It is very uncertain whether probiotics changes withdrawal due to adverse events (52 weeks) compared with 5‐aminosalicylic acid (5‐ASA) (mesalazine) (very low certainty).
It is very uncertain whether probiotics and osmotic laxative changes withdrawal due to adverse events compared with osmotic laxative (very low certainty).
It is very uncertain whether antibiotics plus probiotics changes withdrawals due to adverse events compared with placebo or no intervention (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether probiotic changes withdrawals due to adverse events compared with placebo (very low certainty).
Probiotic showed no clear difference in withdrawals due to adverse events compared with placebo (low certainty).
It is very uncertain whether probiotic + 5‐aminosalicylic acid (5‐ASA) (mesalazine) changes withdrawal due to adverse events (12 to 52 weeks) compared with 5‐ASA (mesalazine) (very low certainty).